These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 23285908)
61. [Explore pros and cons of proproetary Chinese medicines and Western medicines]. Jin YQ; Jiang ZY Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2407-9. PubMed ID: 19157140 [TBL] [Abstract][Full Text] [Related]
62. Designing a Surveillance System in Canada to Detect Adverse Interactions Between Traditional Chinese Medicine and Western Medicine: Issues and Considerations. Zhang J; Ho K Stud Health Technol Inform; 2017; 234():412-417. PubMed ID: 28186077 [TBL] [Abstract][Full Text] [Related]
63. The adverse drug reaction: a clinical opportunity for pharmacists. Miller JD Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281 [TBL] [Abstract][Full Text] [Related]
64. [Analysis of 103 cases with adverse drug reactions induced by sanqizongzaogan injection]. Chen Y; Li Y; Zhu G Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(2):237-9. PubMed ID: 20394303 [TBL] [Abstract][Full Text] [Related]
65. [Cluster analysis on authorized patents of compound traditional Chinese medicines with different efficacy in 2010]. Yang X; Xiao S; Guo Z Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2478-82. PubMed ID: 23234154 [TBL] [Abstract][Full Text] [Related]
66. Modern European monographs for quality control of Chinese herbs. Bauer R; Franz G Planta Med; 2010 Dec; 76(17):2004-11. PubMed ID: 21077026 [TBL] [Abstract][Full Text] [Related]
67. [Effect of Tripterygium wilfordii on gonadal injury and progression of its relative Chinese medicine therapy]. Li Z; Wang Z; Gong C Zhongguo Zhong Yao Za Zhi; 2009 May; 34(9):1067-70. PubMed ID: 19685735 [TBL] [Abstract][Full Text] [Related]
68. [Spontaneous reportintg system data based on shuxuetong injection adverse reactions signal warning analysis]. Jiang JJ; Xiang YY; Xie YM; Shen H Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2994-7. PubMed ID: 24471318 [TBL] [Abstract][Full Text] [Related]
69. On traditional Chinese medicine regulation in China: How quality and safety of use are insured. Hu Q; Calduch RM Pharmacol Res; 2017 May; 119():371-372. PubMed ID: 28258009 [No Abstract] [Full Text] [Related]
70. [Establishment of model of traditional Chinese medicine injections post-marketing safety monitoring]. Guo XE; Zhao YB; Xie YM; Zhao LC; Li YF; Hao Z Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2974-8. PubMed ID: 24471314 [TBL] [Abstract][Full Text] [Related]
71. [Thinking of current situation about decreasing, abolishing and substitution of Chinese medicine species in Shanghanlun]. Ling Y; Zhou C Zhongguo Zhong Yao Za Zhi; 2010 May; 35(9):1209-12. PubMed ID: 20707083 [TBL] [Abstract][Full Text] [Related]
72. Serious cutaneous adverse reactions to traditional Chinese medicines. Batra S Singapore Med J; 2006 Jul; 47(7):647. PubMed ID: 16810443 [No Abstract] [Full Text] [Related]
73. Need for correct identification of herbs in herbal poisoning. But PP Lancet; 1993 Mar; 341(8845):637. PubMed ID: 8094868 [No Abstract] [Full Text] [Related]
74. Quality check of spontaneous adverse drug reaction reporting forms of different countries. Bandekar MS; Anwikar SR; Kshirsagar NA Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1181-5. PubMed ID: 20845409 [TBL] [Abstract][Full Text] [Related]
75. [Study on weight units of chinese medicine in Sui and Tang dynasties]. Zhang RX; Lu Q; Zhang W; Zhang MQ Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(17):2201-4. PubMed ID: 19066070 [TBL] [Abstract][Full Text] [Related]
76. [Comparative study on four kinds of assessment methods of post-marketing safety of Danhong injection]. Li X; Tang J; Meng F; Li C; Xie Y Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2786-8. PubMed ID: 22292365 [TBL] [Abstract][Full Text] [Related]
77. [Pharmacovigilance guidelines for clinical application of traditional Chinese medicine injections]. Fu CK; Liu H; Wang LX; Zou YH; Li MQ; Lin YM; Sun WH; Wei X; Hu YE; Xie YM; Li YY Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4279-4284. PubMed ID: 39307764 [TBL] [Abstract][Full Text] [Related]
78. [Pharmacovigilance idea should be introduced sufficiently into the safety monitoring and evaluation process of Chinese drugs]. Zhang L; Yang XH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Sep; 29(9):843-6. PubMed ID: 19960988 [TBL] [Abstract][Full Text] [Related]
79. Precise reporting of traditional Chinese medicine interventions in randomized controlled trials. Bian ZX; Moher D; Li YP; Wu TX; Dagenais S; Cheng CW; Li J; Li TQ Zhong Xi Yi Jie He Xue Bao; 2008 Jul; 6(7):661-7. PubMed ID: 18601844 [TBL] [Abstract][Full Text] [Related]
80. [Interpretation and analysis of traditional Chinese medicine injection instructions]. Liu MY; Jiao LH; Xie YM; Wang GW; Zheng Q Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2707-9. PubMed ID: 23285915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]